Label Image (Lbl500903485)
Valsartan And Hydrochlorothiazide
Product Images NDC 50090-3485
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 50090-3485). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Valsahctz Figur1)
This is a graph showing the probability of achieving a systolic blood pressure of less than 140 mmHg at week 8. The x-axis represents different baseline systolic blood pressure readings from 140 to 180 mmHg. The y-axis shows the probability of achieving the target blood pressure. The graph compares the effectiveness of Valsartan and hydrochlorothiazide tablets (at a dose of 320/25 mg) to placebo tablets in achieving the target blood pressure. There is no other information available other than the graph.*
Figure 2-3-4 (Valsahctz Figure2 3 4)
The text describes the probability of achieving systolic and diastolic blood pressure goals with the combination of Valsartan and Hydrochlorothiazide tablets at different doses compared to a placebo. The graph figures show the probability of achieving a diastolic blood pressure of less than 90 mmHg or 80 mmHg or a systolic blood pressure of less than 130 mmHg after eight weeks of treatment with different combinations of the drugs.*
Structure (Valsahctz Hctz)
Structure (Valsahctz Valsa)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
